Huawei shows WATCH D3 blood pressure watch at hypertension conference

What Huawei showed Huawei used the ISH-ECS 2026 conference in Dubai, held from 22 to 25 October, to present its new HUAWEI WATCH D3, a wrist-worn blood pressure monitor, according to the company's press release ^[1]. The event combined the 31st International Society of Hypertension Scientific Meeting and the 17th Emirates Cardiac Society Annual Conference. Huawei says it is a member of the society ^[1].

Huawei describes the D3 as the third generation of its wrist-worn blood pressure monitors. It uses what the company calls ultra-narrow airbag oscillometric measurement, a small inflatable cuff built into the watch, and adds a mode that measures blood pressure before and after exercise ^[1]. Huawei says this mode is the first of its kind in the industry to receive EU CE certification under the Medical Device Regulation, along with Class II medical device registration in China ^[1]. These are Huawei's own claims, and the release does not include independent test results.

Research and funding Huawei has set up a Wearable Blood Pressure Technology Innovation Fund with the International Society of Hypertension ^[1]. The first three projects, chosen from more than 80 applications, involve researchers from the University of Colombo, the University of Edinburgh, Peking University People's Hospital and the University of Cambridge ^[1].

The company is also running a Minimally Disruptive ABPM Study with Ruijin Hospital in Shanghai, which it plans to extend to countries including Saudi Arabia and Malaysia ^[1]. ABPM means ambulatory blood pressure monitoring, where readings are taken repeatedly over a day. The study combines all-day photoplethysmography (PPG), a light-based pulse sensor, with cuff readings used for calibration. Huawei says the aim is to reduce the number of cuff measurements from 27 to 7 ^[1]. It adds that users see 24-hour, daytime and night-time averages, plus charts of how their pressure changes through the day ^[1].

What experts said The release quotes Professor George Stergiou, president of the International Society of Hypertension, as calling the D3 a novel, reliable wearable device. It says he also asked for more research into how wrist-cuff monitors are used in clinical practice ^[1]. The release adds that several guidelines, including the 2026 ISH Global Hypertension Practice Guidelines, address validated wrist-worn oscillometric devices for self-monitoring ^[1]. All of this is reported in Huawei's own release rather than by an independent outlet.

Why it matters Huawei says hypertension is one of the most common chronic conditions worldwide and that blood pressure control rates remain low ^[1]. For employers, insurers and health-benefit providers, a watch that takes cuff-based readings during the day could make routine monitoring easier than regular clinic visits.

There are limits. The release gives no price, release date or list of markets for the D3. Anyone considering a wearable for blood pressure should look for independent validation of the specific model, and should discuss readings with a doctor rather than treating the watch as a replacement for medical advice.

For business leaders, the story also shows how health data is becoming a normal feature of consumer gadgets, with the research partnerships that go with it.

Source: Huawei via PR Newswire — HUAWEI WATCH D3 Debuts at ISH-ECS 2026, Bringing Advanced Blood Pressure Monitoring into Everyday Life